Skip to main content
. 2013 Jul 10;8(7):e70190. doi: 10.1371/journal.pone.0070190

Table 2. Analysis of anti-PCSK9 variants following 2nd round of enrichment.

Sequence ID No of Clones of Identical Sequence Average KD nM ELISA Titer (µg/mL)
S2-10 28 0.99±0.037 30.9±9.7
S2-15 11 60.75±15.46 26.2±9.3
S2-32 1 559.5 25.3
AX Parent Control (n=8) 2.25 10.5±4.2